Delafloxacin Meglumine

Cysolvia® is one of brands under Miedykol® a high-end and certified active pharmaceutical ingredients (APIs) and pharmaceutical intermediates manufacturer in China, mainly providing various APIs products and customized production (CMO/CDMO). We produce the delafloxacin meglumine product which was developed earlist by Japanese pharma company Wakunaga and approved in multiple countries later. It is known as a fluoroquinolone antibiotic effective against a number of pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), Streptococci, Enterobacteriaceae, and Pseudomonas aeruginosa. At Miedykol, we produce the innovative and market much-needed active ingredient products for special disease drugs managing arrhythmia, convulsion, postmenopausal osteoporosis, etc.. We also support your healthcare project and clinical therapies with the tailored production and integrative preparation solutions. Reach out to us for further information.